Apple says it will disable a blood-oxygen monitoring feature on its two most popular watches in the U.S. beginning Thursday to comply with a court-ordered revival of a sales ban stemming from a patent dispute. The decision to turn off the blood-oxygen sensor for consumers who buy either the Apple Watch Series 9 or Ultra 2 in the U.S. came …
